Notice of Closed Meeting, 5440 [2020-01621]
Download as PDF
<![CDATA[
5440
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
practice-based evidence and issues
recommendations. CPSTF
recommendations are not mandates for
compliance or resource allocation.
Instead, they provide information about
evidence-based options that decision
makers and stakeholders can consider
when they are determining what best
meets the specific needs, preferences,
available resources, and constraints of
their jurisdictions and constituents. The
CPSTF’s recommendations, along with
the systematic reviews of the evidence
on which they are based, are compiled
in the The Community Guide.
Matters proposed for discussion: The
CPSTF will discuss the 2020 process for
establishing its priority topics for 2021–
2025 during a closed session the first
half of the day. During the afternoon
session which is open to the public, the
CPSTF will deliberate on systematic
reviews of literature related to the
following: HIV Prevention: Clinical
Decision Support Systems to Increase
HIV Screening; Cardiovascular Disease
Prevention and Control: Economics of
Pharmacy-Based Interventions to
Increase Medication Adherence; and
one or more proposals for new reviews
in the areas of mental health, sleep
health, tobacco prevention and control.
The agenda is subject to change without
prior notice; however, agenda updates
will be posted on the the Community
Guide website
(www.thecommunityguide.org).
Dated: January 27, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CK–20–004, Prevention Epicenters
Program: Protecting Patients from
Infections, Antibiotics Resistance and
Other Adverse Events.
Date: May 21, 2020.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
Jkt 250001
[FR Doc. 2020–01621 Filed 1–29–20; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
16:56 Jan 29, 2020
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–01620 Filed 1–29–20; 8:45 am]
[FR Doc. 2020–01732 Filed 1–29–20; 8:45 am]
VerDate Sep<11>2014
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–20–005, Rapid-Cycle Survey
Collaborative for Patient and Provider
Input on Immunization Issues.
Date: April 21, 2020.
Time: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
FOR FURTHER INFORMATION CONTACT:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), ICD–10 Coordination and
Maintenance (C&M) Committee
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention, National Center
for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, announces the
following meeting of the ICD–10
Coordination and Maintenance (C&M)
Committee meeting. This meeting is
open to the public, limited only by the
space available. The meeting room
accommodates approximately 240
SUMMARY:
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Page 5440]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01621]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--RFA-IP-20-005, Rapid-Cycle Survey
Collaborative for Patient and Provider Input on Immunization Issues.
Date: April 21, 2020.
Time: 10:00 a.m.-5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road, NE, Mailstop US8-1,
Atlanta, Georgia 30329-4027; Telephone: (404) 718-8833; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-01621 Filed 1-29-20; 8:45 am]
BILLING CODE 4163-18-P
